炎症性肠病（IBD）：临床诊断与治疗
Inflammatory Bowel Disease (IBD): Clinical Diagnosis and Treatment.
作者信息
Silva Isabel, da Silva Moisés Tolentino Bento
机构信息
Laboratory of Pharmacology and Neurobiology, Center for Drug Discovery and Innovative Medicines (MedInUP)/RISE-Health: Health Research Network, Department of Immuno-Physiology and Pharmacology, School of Medicine and Biomedical Science-University of Porto (ICBAS-UP), 4050-313 Porto, Portugal.
Laboratory of Physiology, Center for Drug Discovery and Innovative Medicines (MedInUP)/RISE-Health: Health Research Network, Department of Immuno-Physiology and Pharmacology, School of Medicine and Biomedical Science-University of Porto (ICBAS-UP), 4050-313 Porto, Portugal.
出版信息
J Clin Med. 2025 Sep 4;14(17):6237. doi: 10.3390/jcm14176237.
Abstract
Inflammatory bowel disease (IBD) is a pathological condition that occurs in two different forms: Crohn's disease (CD) and ulcerative colitis (UC) [...].
摘要
炎症性肠病（IBD）是一种以两种不同形式出现的病理状况：克罗恩病（CD）和溃疡性结肠炎（UC）[...]。
相似文献
1
Inflammatory Bowel Disease (IBD): Clinical Diagnosis and Treatment.炎症性肠病（IBD）：临床诊断与治疗
J Clin Med. 2025 Sep 4;14(17):6237. doi: 10.3390/jcm14176237.
2
Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.中重度溃疡性结肠炎和克罗恩病对性活动的影响：来自炎症性肠病经历的沟通需求与特征（CONFIDE）调查的美国和欧洲患者观点
Curr Med Res Opin. 2025 Jul 17:1-14. doi: 10.1080/03007995.2025.2530736.
3
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
4
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.维多珠单抗治疗的炎症性肠病患者的医疗资源利用和生产损失：瑞典前瞻性多中心SVEAH研究的结果
Therap Adv Gastroenterol. 2025 Jul 17;18:17562848251352023. doi: 10.1177/17562848251352023. eCollection 2025.
5
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.缺血性中风可能增加克罗恩病和溃疡性结肠炎的风险：来自双向孟德尔随机化研究的证据。
World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13.
6
Artificial intelligence in inflammatory bowel disease endoscopy - a review of current evidence and a critical perspective on future challenges.炎症性肠病内镜检查中的人工智能——当前证据综述及对未来挑战的批判性观点
Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251350896. doi: 10.1177/17562848251350896. eCollection 2025.
7
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.炎症性肠病中部分缓解的定义：德尔菲共识与经济学评估
Therap Adv Gastroenterol. 2025 Aug 18;18:17562848251360907. doi: 10.1177/17562848251360907. eCollection 2025.
8
Identifying inflammatory bowel disease subtypes: a comprehensive exploration of transcriptomic data and machine learning-based approaches.识别炎症性肠病亚型：对转录组数据和基于机器学习方法的全面探索
Therap Adv Gastroenterol. 2025 Aug 12;18:17562848251362391. doi: 10.1177/17562848251362391. eCollection 2025.
9
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: A Discrete Choice Experiment Among Patients in Five Non-Western Countries.炎症性肠病患者对治疗属性的偏好：五个非西方国家患者的离散选择实验
Adv Ther. 2025 Jun 17. doi: 10.1007/s12325-025-03249-w.
10
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.西班牙炎症性肠病（溃疡性结肠炎和克罗恩病）的流行病学、临床、患者报告和经济负担：系统评价。
Adv Ther. 2023 May;40(5):1975-2014. doi: 10.1007/s12325-023-02473-6. Epub 2023 Mar 16.
本文引用的文献
1
Intestinal Ultrasound: Advancing Towards Broader Adoption-Insights from a National Survey in Turkey.肠道超声：迈向更广泛应用——来自土耳其全国性调查的见解
J Clin Med. 2025 Jul 8;14(14):4817. doi: 10.3390/jcm14144817.
2
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025.英国胃肠病学会成人炎症性肠病指南：2025年版
Gut. 2025 Jun 23;74(Suppl 2):s1-s101. doi: 10.1136/gutjnl-2024-334395.
3
Neutrophil Elastase and Elafin in Inflammatory Bowel Diseases: Urinary Biomarkers Reflecting Intestinal Barrier Dysfunction and Proteolytic Activity.炎症性肠病中的中性粒细胞弹性蛋白酶和elafin：反映肠道屏障功能障碍和蛋白水解活性的尿液生物标志物
J Clin Med. 2025 Apr 4;14(7):2466. doi: 10.3390/jcm14072466.
4
Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases.体育锻炼作为胃肠道疾病的一种治疗方法。
J Clin Med. 2025 Mar 3;14(5):1708. doi: 10.3390/jcm14051708.
5
The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease.钙卫蛋白在炎症性肠病诊断和治疗中的作用
Int J Mol Sci. 2025 Feb 25;26(5):1996. doi: 10.3390/ijms26051996.
6
Role of Mirikizumab in the Treatment of Inflammatory Bowel Disease-From Bench to Bedside.Mirikizumab在炎症性肠病治疗中的作用——从实验室到临床
J Clin Med. 2025 Feb 5;14(3):1001. doi: 10.3390/jcm14031001.
7
Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of inflammatory bowel disease.粪便钙卫蛋白、肠道超声及其联合应用于炎症性肠病的诊断
Clin Res Hepatol Gastroenterol. 2025 Mar;49(3):102549. doi: 10.1016/j.clinre.2025.102549. Epub 2025 Feb 3.
8
Physiological Data Collected From Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares.从可穿戴设备收集的生理数据可识别和预测炎症性肠病发作。
Gastroenterology. 2025 May;168(5):939-951.e5. doi: 10.1053/j.gastro.2024.12.024. Epub 2025 Jan 16.
9
Exploring Dietary- and Disease-Related Influences on Flatulence and Fecal Odor Perception in Inflammatory Bowel Disease.探索饮食和疾病相关因素对炎症性肠病中肠胃胀气和粪便气味感知的影响。
J Clin Med. 2024 Dec 29;14(1):137. doi: 10.3390/jcm14010137.
10
Effectiveness of Telemedicine in Inflammatory Bowel Disease in Russia: TIGE-Rus (Telemonitoring for IBD Goodness Examination in Russia) Study Protocol of a Randomized Controlled Trial.俄罗斯远程医疗在炎症性肠病中的有效性：TIGE-Rus（俄罗斯炎症性肠病良好检查远程监测）随机对照试验研究方案
J Clin Med. 2024 Dec 18;13(24):7734. doi: 10.3390/jcm13247734.
Zotero 插件